SEC Comment Letter 0000000000-23-004308 to Biophytis SA (BPTSY) (CIK 0001768946)
Biophytis SA (BPTSY) (CIK 0001768946)
Date: April 27, 2023 · CIK: 0001768946 · Accession: 0000000000-23-004308
AI Filing Summary & Sentiment
File numbers found in text: 333-271385
Letter
United States securities and exchange commission logo April 27, 2023 Stanislas Veillet Chief Executive Officer and Chairman Biophytis S.A. Sorbonne University—BC 9, Bâtiment A 4ème étage 4 place Jussieu 75005 Paris, France Re:Biophytis S.A. Registration Statement on Form F-3 Filed April 21, 2023 File No. 333-271385 Dear Stanislas Veillet: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Wendy Grasso
Show Raw Text
United States securities and exchange commission logo
April 27, 2023
Stanislas Veillet
Chief Executive Officer and Chairman
Biophytis S.A.
Sorbonne University—BC 9, Bâtiment A 4ème étage
4 place Jussieu
75005 Paris, France
Re:Biophytis S.A.
Registration Statement on Form F-3
Filed April 21, 2023
File No. 333-271385
Dear Stanislas Veillet:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Wendy Grasso